Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC772523398;23399;23400 chr2:178720589;178720588;178720587chr2:179585316;179585315;179585314
N2AB740822447;22448;22449 chr2:178720589;178720588;178720587chr2:179585316;179585315;179585314
N2A648119666;19667;19668 chr2:178720589;178720588;178720587chr2:179585316;179585315;179585314
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATT
  • RefSeq wild type template codon: TAA
  • Domain: Ig-62
  • Domain position: 24
  • Structural Position: 35
  • Q(SASA): 0.11
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/M rs1270184889 None 0.81 N 0.673 0.362 0.449669948863 gnomAD-4.0.0 1.59241E-06 None None None None N None 0 0 None 0 0 None 0 0 2.85999E-06 0 0
I/T None None 0.549 N 0.669 0.423 0.631214040921 gnomAD-4.0.0 1.20033E-06 None None None None N None 0 0 None 0 0 None 0 0 1.31251E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.9119 likely_pathogenic 0.9074 pathogenic -2.541 Highly Destabilizing 0.009 N 0.405 neutral None None None None N
I/C 0.951 likely_pathogenic 0.9502 pathogenic -1.959 Destabilizing 0.992 D 0.739 prob.delet. None None None None N
I/D 0.9972 likely_pathogenic 0.9967 pathogenic -2.801 Highly Destabilizing 0.92 D 0.813 deleterious None None None None N
I/E 0.9937 likely_pathogenic 0.993 pathogenic -2.545 Highly Destabilizing 0.92 D 0.795 deleterious None None None None N
I/F 0.4218 ambiguous 0.4062 ambiguous -1.458 Destabilizing 0.681 D 0.703 prob.neutral N 0.498200396 None None N
I/G 0.9857 likely_pathogenic 0.9837 pathogenic -3.089 Highly Destabilizing 0.617 D 0.761 deleterious None None None None N
I/H 0.9859 likely_pathogenic 0.9851 pathogenic -2.575 Highly Destabilizing 0.992 D 0.785 deleterious None None None None N
I/K 0.9835 likely_pathogenic 0.9817 pathogenic -1.662 Destabilizing 0.92 D 0.785 deleterious None None None None N
I/L 0.1259 likely_benign 0.1162 benign -0.931 Destabilizing 0.001 N 0.187 neutral N 0.444539269 None None N
I/M 0.2155 likely_benign 0.2043 benign -1.171 Destabilizing 0.81 D 0.673 neutral N 0.501842617 None None N
I/N 0.9575 likely_pathogenic 0.9477 pathogenic -2.098 Highly Destabilizing 0.963 D 0.813 deleterious N 0.502349596 None None N
I/P 0.9932 likely_pathogenic 0.9923 pathogenic -1.452 Destabilizing 0.92 D 0.813 deleterious None None None None N
I/Q 0.9858 likely_pathogenic 0.9846 pathogenic -1.897 Destabilizing 0.972 D 0.813 deleterious None None None None N
I/R 0.9765 likely_pathogenic 0.9746 pathogenic -1.564 Destabilizing 0.92 D 0.814 deleterious None None None None N
I/S 0.959 likely_pathogenic 0.9539 pathogenic -2.789 Highly Destabilizing 0.379 N 0.713 prob.delet. N 0.479961352 None None N
I/T 0.913 likely_pathogenic 0.9057 pathogenic -2.383 Highly Destabilizing 0.549 D 0.669 neutral N 0.496429527 None None N
I/V 0.139 likely_benign 0.1357 benign -1.452 Destabilizing 0.007 N 0.169 neutral N 0.363757752 None None N
I/W 0.9815 likely_pathogenic 0.9803 pathogenic -1.792 Destabilizing 0.992 D 0.771 deleterious None None None None N
I/Y 0.9042 likely_pathogenic 0.8925 pathogenic -1.549 Destabilizing 0.92 D 0.777 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.